Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsJonathon Torchia, Diane K. Birks, Brian Golbourn et al.|Cancer Cell|2016Cited by 259
The molecular basis of breast cancer pathological phenotypesYujing J. Heng, Andrew H. Beck, Nicole B. Johnson et al.|The Journal of Pathology|2016Cited by 114
Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapiesJenna E. van Leeuwen, Deena M.A. Gendoo|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 2
Computational pharmacogenomic screen identifies drugs that phenocopy dipyridamole and potentiate anti-breast cancer activity of statinsJenna E. van Leeuwen, Deena M.A. Gendoo|Research Square|2021Cited by 0